D

Day One Biopharmaceuticals Inc
NASDAQ:DAWN

Watchlist Manager
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Watchlist
Price: 16.17 USD 0.87% Market Closed
Updated: May 19, 2024

Day One Biopharmaceuticals Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Day One Biopharmaceuticals Inc
Research & Development Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
D
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Research & Development
-$130.5m
CAGR 3-Years
-143%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Research & Development
-$7.3B
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Research & Development
-$6B
CAGR 3-Years
18%
CAGR 5-Years
-3%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Research & Development
-$5B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Research & Development
-$3.5B
CAGR 3-Years
-24%
CAGR 5-Years
-19%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Research & Development
-$4.6B
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-17%

See Also

What is Day One Biopharmaceuticals Inc's Research & Development?
Research & Development
-130.5m USD

Based on the financial report for Dec 31, 2023, Day One Biopharmaceuticals Inc's Research & Development amounts to -130.5m USD.

What is Day One Biopharmaceuticals Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-143%

Over the last year, the Research & Development growth was -52%. The average annual Research & Development growth rates for Day One Biopharmaceuticals Inc have been -143% over the past three years .